BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21178064)

  • 41. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.
    Pastorino U; Landoni C; Marchianò A; Calabrò E; Sozzi G; Miceli R; Picchio M; Mariani L; Messa C; Fazio F
    J Thorac Oncol; 2009 Nov; 4(11):1352-6. PubMed ID: 19861905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
    Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
    J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
    Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
    Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. (18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
    van Gool MH; Aukema TS; Schaake EE; Rijna H; Codrington HE; Valdés Olmos RA; Teertstra HJ; van Pel R; Burgers SA; van Tinteren H; Klomp HM
    Ann Surg Oncol; 2014 Sep; 21(9):2831-7. PubMed ID: 24845729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of CT-based lean-body SUV.
    Hamill JJ; Sunderland JJ; LeBlanc AK; Kojima CJ; Wall J; Martin EB
    Med Phys; 2013 Sep; 40(9):092504. PubMed ID: 24007180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation.
    Caoili EM; Korobkin M; Brown RK; Mackie G; Shulkin BL
    Acad Radiol; 2007 Apr; 14(4):468-75. PubMed ID: 17368217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
    Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
    Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
    Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S
    Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI; Kim SK; Paeng JC; Lee HY
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET.
    Lin CY; Ding HJ; Lin T; Lin CC; Kuo TH; Kao CH
    Clin Imaging; 2010; 34(2):109-12. PubMed ID: 20189073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic glucose uptake is increased in association with elevated serum γ-glutamyl transpeptidase and triglyceride.
    Hong SP; Noh TS; Moon SH; Cho YS; Lee EJ; Choi JY; Kim BT; Lee KH
    Dig Dis Sci; 2014 Mar; 59(3):607-13. PubMed ID: 24326630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intense FDG activity in focal hepatic steatosis.
    Le Y; Chen Y; Huang Z; Cai L; Zhang L
    Clin Nucl Med; 2014 Jul; 39(7):669-72. PubMed ID: 24873789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FDG PET/CT of the non-malignant liver in an increasingly obese world population.
    Keramida G; Peters AM
    Clin Physiol Funct Imaging; 2020 Sep; 40(5):304-319. PubMed ID: 32529712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Revisiting Weight-Normalized SUV and Lean-Body-Mass-Normalized SUV in PET Studies.
    Sarikaya I; Albatineh AN; Sarikaya A
    J Nucl Med Technol; 2020 Jun; 48(2):163-167. PubMed ID: 31604893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The negative impact of fatty liver on maximum standard uptake value of liver on FDG PET.
    Lin CY; Lin WY; Lin CC; Shih CM; Jeng LB; Kao CH
    Clin Imaging; 2011; 35(6):437-41. PubMed ID: 22040787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.